CEO Sidesteps Big Pharma’s Pricing Practices; Pushes Proposals That Would Boost Drug Company Profits and Incentivize Price Hikes During a recent interview on Bloomberg’s “Balance of Power,” Pfizer CEO Albert Bourla claimed the pharmaceutical industry is willing to be a helpful partner in reducing “significantly the cost of medicines.” What Bourla did not mention…
Lawmakers Must Advance Solutions to Lower Drug Prices For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing…
Broad-based Opposition to Egregious Launch Price on Drug With Unproven Clinical Benefit Adds to Momentum to Hold Big Pharma Accountable Last week, the U.S. Food and Drug Administration (FDA)…
Troubling for Public Health Institution to Depart from Established Norms to Support Drug of Questionable Efficacy with Unjustifiable Price Tag For Immediate Release Contact: Jon Conradi 860-235-3884…
AARP Study Finds Brand Name Drug Companies Increased Prices Above Rate of Inflation on 90 Percent of Best-Selling Part D Medications In case you missed it, AARP released a new report Monday…
For far too long Big Pharma has used the excuse that research and development (R&D) costs justify out-of-control prescription drug prices and that solutions to lower prices threaten innovation…
Campaign Calls for Promises Made to the American People to Lower Prescription Drug Prices to Become Promises Kept For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected]…
Time for the Administration and Congress to Convert Promises Made Into Promises Kept For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign…
House Oversight Lawmakers Commit to Bipartisan Action to Hold Big Pharma Accountable During Explosive Hearing on Out-of-Control Drug Prices During a hearing Tuesday before the U.S. House Committee…
AbbVie CEO Headed for Capitol Hill to Answer for Indefensible Anti-Competitive & Price-Hiking Tactics on World’s Best-Selling Drug On Tuesday, lawmakers in the U.S. House Committee on…